Role of conformational fluctuations in the enzymatic reaction of HIV-1 protease.

[1]  M. Parrinello,et al.  Ab initio molecular dynamics-based assignment of the protonation state of pepstatin A/HIV-1 protease cleavage site. , 2001, Journal of the American Chemical Society.

[2]  J. Louis,et al.  Characterization of two hydrophobic methyl clusters in HIV-1 protease by NMR spin relaxation in solution. , 2001, Journal of molecular biology.

[3]  A Maritan,et al.  Molecular dynamics studies on HIV‐1 protease: Drug resistance and folding pathways , 2001, Proteins.

[4]  W. Scott,et al.  Curling of flap tips in HIV-1 protease as a mechanism for substrate entry and tolerance of drug resistance. , 2000, Structure.

[5]  S. Pantano,et al.  Proton dynamics in an enzyme model substrate: an ab initio molecular dynamics study , 2000 .

[6]  C. Schiffer,et al.  How does a symmetric dimer recognize an asymmetric substrate? A substrate complex of HIV-1 protease. , 2000, Journal of molecular biology.

[7]  Thomas C. Bruice,et al.  Comparison of the Dynamics for Ground-State and Transition-State Structures in the Active Site of Catechol O-Methyltransferase , 2000 .

[8]  Paolo Carloni,et al.  Conformational flexibility of the catalytic Asp dyad in HIV‐1 protease: An ab initio study on the free enzyme , 2000, Proteins.

[9]  U. Rothlisberger,et al.  A comparative study of galactose oxidase and active site analogs based on QM/MM Car-Parrinello simulations , 2000, JBIC Journal of Biological Inorganic Chemistry.

[10]  Paolo Carloni,et al.  Key Steps of the cis-Platin-DNA Interaction: Density Functional Theory-Based Molecular Dynamics Simulations , 2000 .

[11]  C. Brooks,et al.  Protein Dynamics in Enzymatic Catalysis: Exploration of Dihydrofolate Reductase , 2000 .

[12]  S. Gulnik,et al.  HIV protease: enzyme function and drug resistance. , 2000, Vitamins and hormones.

[13]  T. N. Bhat,et al.  The Protein Data Bank , 2000, Nucleic Acids Res..

[14]  C. Boucher,et al.  Increased fitness of drug resistant HIV-1 protease as a result of acquisition of compensatory mutations during suboptimal therapy. , 1999, AIDS.

[15]  G. Folkers,et al.  Conformational analysis of dimethyl phosphate in aqueous solution: a density functional theory-based molecular dynamics study , 1999 .

[16]  A. Amadei,et al.  On the convergence of the conformational coordinates basis set obtained by the essential dynamics analysis of proteins' molecular dynamics simulations , 1999, Proteins.

[17]  Masayuki Hata,et al.  Hydrolysis Mechanism of the Phenylalanine−Proline Peptide Bond Specific to HIV-1 Protease: Investigation by the ab Initio Molecular Orbital Method , 1999 .

[18]  P. Carloni,et al.  Serine proteases: An ab initio molecular dynamics study , 1999, Proteins.

[19]  J. Martinez-Picado,et al.  Replicative Fitness of Protease Inhibitor-Resistant Mutants of Human Immunodeficiency Virus Type 1 , 1999, Journal of Virology.

[20]  Michele Parrinello,et al.  Water Molecule Dipole in the Gas and in the Liquid Phase , 1999 .

[21]  R. Dutzler,et al.  X-ray structure and conformational dynamics of the HIV-1 protease in complex with the inhibitor SDZ283-910: agreement of time-resolved spectroscopy and molecular dynamics simulations. , 1999, Journal of molecular biology.

[22]  M. Summers,et al.  Structural biology of HIV. , 1999, Journal of molecular biology.

[23]  J. Collins,et al.  Dynamic Flexibility of Protein−Inhibitor Complexes: A Study of the HIV-1 Protease/KNI-272 Complex , 1998 .

[24]  T. C. Bruice,et al.  Importance of Correlated Motions in Forming Highly Reactive Near Attack Conformations in Catechol O-Methyltransferase , 1998 .

[25]  Michiel Sprik,et al.  Free energy from constrained molecular dynamics , 1998 .

[26]  P. Kollman,et al.  Pathways to a protein folding intermediate observed in a 1-microsecond simulation in aqueous solution. , 1998, Science.

[27]  A. Warshel.  Electrostatic Origin of the Catalytic Power of Enzymes and the Role of Preorganized Active Sites* , 1998, The Journal of Biological Chemistry.

[28]  A Wlodawer,et al.  Drug-resistant HIV-1 proteases identify enzyme residues important for substrate selection and catalytic rate. , 1998, Biochemistry.

[29]  A. Fersht.  Structure and mechanism in protein science , 1998 .

[30]  Yun-Xing Wang,et al.  Flexibility and Function in HIV Protease: Dynamics of the HIV-1 Protease Bound to the Asymmetric Inhibitor Kynostatin 272 (KNI-272) , 1998 .

[31]  Ab initio molecular dynamics study of the reaction of water with formaldehyde in sulfuric acid solution. , 1998 .

[32]  Astronomy,et al.  Maximally-localized Wannier functions for disordered systems: application to amorphous silicon , 1998, cond-mat/9804019.

[33]  F. López-Ortiz,et al.  Theoretical Proposal of a Catalytic Mechanism for the HIV-1 Protease Involving an Enzyme-Bound Tetrahedral Intermediate , 1998 .

[34]  U. Rothlisberger.  Ab initio and hybrid molecular dynamics simulations of the active site of human carbonic anhydrase II: a test case study , 1998 .

[35]  A Wlodawer,et al.  Inhibitors of HIV-1 protease: a major success of structure-assisted drug design. , 1998, Annual review of biophysics and biomolecular structure.

[36]  Alessandro Curioni,et al.  DENSITY FUNCTIONAL THEORY-BASED MOLECULAR DYNAMICS SIMULATION OF ACID-CATALYZED CHEMICAL REACTIONS IN LIQUID TRIOXANE , 1997 .

[37]  N. Marzari,et al.  Maximally localized generalized Wannier functions for composite energy bands , 1997, cond-mat/9707145.

[38]  C. Debouck,et al.  The 80's loop (residues 78 to 85) is important for the differential activity of retroviral proteases. , 1997, Journal of molecular biology.

[39]  H. B. Schock,et al.  Mutational Anatomy of an HIV-1 Protease Variant Conferring Cross-resistance to Protease Inhibitors in Clinical Trials , 1996, The Journal of Biological Chemistry.

[40]  R. Stroud,et al.  Three-dimensional structures of HIV-1 and SIV protease product complexes. , 1996, Biochemistry.

[41]  A. Bax,et al.  Anisotropic rotational diffusion of perdeuterated HIV protease from 15N NMR relaxation measurements at two magnetic fields , 1996, Journal of biomolecular NMR.

[42]  S. Benkovic,et al.  A perspective on biological catalysis , 1996, Nature Structural Biology.

[43]  H Liu,et al.  A combined quantum/classical molecular dynamics study of the catalytic mechanism of HIV protease. , 1996, Journal of molecular biology.

[44]  David J. Livingston,et al.  Kinetic Characterization of Human Immunodeficiency Virus Type-1 Protease-resistant Variants* , 1996, The Journal of Biological Chemistry.

[45]  T. Darden,et al.  An ab Initio Quantum Mechanical Model for the Catalytic Mechanism of HIV-1 Protease , 1996 .

[46]  R E Cachau,et al.  Inhibition and catalytic mechanism of HIV-1 aspartic protease. , 1996, Journal of molecular biology.

[47]  T. Darden,et al.  A smooth particle mesh Ewald method , 1995 .

[48]  P. Kollman,et al.  A Second Generation Force Field for the Simulation of Proteins, Nucleic Acids, and Organic Molecules , 1995 .

[49]  Jack R. Collins,et al.  Flap opening in HIV-1 protease simulated by ‘activated’ molecular dynamics , 1995, Nature Structural Biology.

[50]  Ad Bax,et al.  Flexibility and function in HIV-1 protease , 1995, Nature Structural Biology.

[51]  B. Montgomery Pettitt,et al.  Nanosecond Dynamics and Structure of a Model DNA Triple Helix in Saltwater Solution , 1995 .

[52]  D. Ho,et al.  Selection and analysis of human immunodeficiency virus type 1 variants with increased resistance to ABT-538, a novel protease inhibitor , 1995, Journal of virology.

[53]  R. Lumry.  On the interpretation of data from isothermal processes. , 1995, Methods in enzymology.

[54]  I. Weber,et al.  Molecular dynamics simulations of HIV-1 protease with peptide substrate. , 1994, Protein engineering.

[55]  I. Boros,et al.  Substrate-dependent mechanisms in the catalysis of human immunodeficiency virus protease. , 1994, Biochemistry.

[56]  M. Parrinello,et al.  Electronic structure optimization in plane-wave-based density functional calculations by direct inversion in the iterative subspace , 1994 .

[57]  H. Berendsen,et al.  Essential dynamics of proteins , 1993, Proteins.

[58]  Barnett,et al.  Born-Oppenheimer molecular-dynamics simulations of finite systems: Structure and dynamics of (H2O)2. , 1993, Physical review. B, Condensed matter.

[59]  T. Darden,et al.  Particle mesh Ewald: An N⋅log(N) method for Ewald sums in large systems , 1993 .

[60]  T. Darden,et al.  Molecular dynamics simulation of HIV-1 protease in a crystalline environment and in solution. , 1993, Biochemistry.

[61]  A. Wlodawer,et al.  Structure-based inhibitors of HIV-1 protease. , 1993, Annual review of biochemistry.

[62]  Michael H. Gelb,et al.  Crystallographic analysis of transition state mimics bound to penicillopepsin: difluorostatine- and difluorostatone-containing peptides. , 1994 .

[63]  García,et al.  Large-amplitude nonlinear motions in proteins. , 1992, Physical review letters.

[64]  T L Blundell,et al.  Direct observation by X‐ray analysis of the tetrahedral “intermediate” of aspartic proteinases , 1992, Protein science : a publication of the Protein Society.

[65]  S. Carr,et al.  Human immunodeficiency virus-1 protease. 1. Initial velocity studies and kinetic characterization of reaction intermediates by 18O isotope exchange. , 1991, Biochemistry.

[66]  T. Meek,et al.  Human immunodeficiency virus-1 protease. 2. Use of pH rate studies and solvent kinetic isotope effects to elucidate details of chemical mechanism. , 1991, Biochemistry.

[67]  A. Tomasselli,et al.  A cumulative specificity model for proteases from human immunodeficiency virus types 1 and 2, inferred from statistical analysis of an extended substrate data base. , 1991, The Journal of biological chemistry.

[68]  A Wlodawer,et al.  Structure at 2.5-A resolution of chemically synthesized human immunodeficiency virus type 1 protease complexed with a hydroxyethylene-based inhibitor. , 1991, Biochemistry.

[69]  N Go,et al.  Projection of monte carlo and molecular dynamics trajectories onto the normal mode axes: Human lysozyme , 1991, Proteins.

[70]  Martins,et al.  Efficient pseudopotentials for plane-wave calculations. , 1991, Physical review. B, Condensed matter.

[71]  A. Wlodawer,et al.  The complexities of AIDS : an assessment of the HIV protease as a therapeutic target , 1991 .

[72]  J. Springer,et al.  Structure and function of retroviral proteases. , 1991, Annual review of biophysics and biophysical chemistry.

[73]  R. Dixon,et al.  Crystallographic analysis of a complex between human immunodeficiency virus type 1 protease and acetyl-pepstatin at 2.0-A resolution. , 1991, The Journal of biological chemistry.

[74]  J. C. Martin,et al.  Domain communication in the dynamical structure of human immunodeficiency virus 1 protease. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[75]  D. Norbeck,et al.  Design, activity, and 2.8 A crystal structure of a C2 symmetric inhibitor complexed to HIV-1 protease. , 1990, Science.

[76]  Tomi K. Sawyer,et al.  A synthetic HIV-1 protease inhibitor with antiviral activity arrests HIV-like particle maturation. , 1990, Disease markers.

[77]  I. Pastan,et al.  Interdomain hydrolysis of a truncated Pseudomonas exotoxin by the human immunodeficiency virus-1 protease. , 1990, The Journal of biological chemistry.

[78]  D. Davies,et al.  The structure and function of the aspartic proteinases. , 1990 .

[79]  C. Debouck,et al.  Inhibition of human immunodeficiency virus 1 protease in vitro: rational design of substrate analogue inhibitors. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[80]  A Wlodawer,et al.  Structure of complex of synthetic HIV-1 protease with a substrate-based inhibitor at 2.3 A resolution. , 1989, Science.

[81]  G. Ciccotti,et al.  Constrained reaction coordinate dynamics for the simulation of rare events , 1989 .

[82]  Giovanni Ciccotti,et al.  Constrained molecular dynamics and the mean potential for an ion pair in a polar solvent , 1989 .

[83]  A. Becke,et al.  Density-functional exchange-energy approximation with correct asymptotic behavior. , 1988, Physical review. A, General physics.

[84]  Parr,et al.  Development of the Colle-Salvetti correlation-energy formula into a functional of the electron density. , 1988, Physical review. B, Condensed matter.

[85]  C. Debouck,et al.  Human immunodeficiency virus protease expressed in Escherichia coli exhibits autoprocessing and specific maturation of the gag precursor. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[86]  E. Padlan,et al.  Binding of a reduced peptide inhibitor to the aspartic proteinase from Rhizopus chinensis: implications for a mechanism of action. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[87]  Car,et al.  Unified approach for molecular dynamics and density-functional theory. , 1985, Physical review letters.

[88]  H. Berendsen,et al.  Molecular dynamics with coupling to an external bath , 1984 .

[89]  M Karplus,et al.  Dynamics of proteins: elements and function. , 1983, Annual review of biochemistry.

[90]  A. Szabó,et al.  Model-free approach to the interpretation of nuclear magnetic resonance relaxation in macromolecules. 1. Theory and range of validity , 1982 .

[91]  A. Szabó,et al.  Model-free approach to the interpretation of nuclear magnetic resonance relaxation in macromolecules. 2. Analysis of experimental results , 1982 .

[92]  M Karplus,et al.  Picosecond dynamics of tyrosine side chains in proteins. , 1979, Biochemistry.

[93]  G. Ciccotti,et al.  Numerical Integration of the Cartesian Equations of Motion of a System with Constraints: Molecular Dynamics of n-Alkanes , 1977 .

[94]  A. Berger,et al.  Mapping the active site of papain with the aid of peptide substrates and inhibitors. , 1970, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.

[95]  Henry Eyring,et al.  Conformation Changes of Proteins , 1954 .